Debates & Insight Sponsored Available on demand: Measuring the cost of the right interve... Available on Demand: Measuring the cost of the right interventions in diabetes.
Views & Analysis Cancer central to ‘Question Time’-style debate Topics, ranging from the seven-days- a-week NHS to Brexit, were on the oncology panel's agenda.
News British pharma, biotech reiterate ‘Remain’ support On the eve of the hugely important referendum, the result is too close to call.
News Janssen's RA candidate among hot topics at EULAR But attendees warned to expect "oceanic" weather.
Pharma Market Access Accelerated Access Review: no panacea for UK pharma What can the AAR do for the UK pharma industry, the health service and patients?
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.